Evidence map›Paper›PMID 37143657›Full record

ArticleFrontiers in immunology2023

Selma Belhimeur, Sylvie Briquet, Roger Peronet, Jennifer Pham, Pierre-Henri Commere, Pauline Formaglio, Rogerio Amino, Artur Scherf, Olivier Silvie, Salaheddine Mecheri

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Selma BelhimeurInstitut Pasteur, Université Paris Cité, CNRS ERL9195 and Inserm U1201, Unité de Biologie des Interactions Hôte Parasites, Paris, France.
Sylvie BriquetSorbonne Université, Inserm U1135, CNRS ERL 8255, Paris, France.
Roger PeronetInstitut Pasteur, Université Paris Cité, CNRS ERL9195 and Inserm U1201, Unité de Biologie des Interactions Hôte Parasites, Paris, France.
Jennifer PhamInstitut Pasteur, Université Paris Cité, Centre d'élevage et de production des anophèles (CEPIA), Paris, France.
Pierre-Henri CommereInstitut Pasteur, Université Paris Cité, Imagopole, Paris, France.
Pauline FormaglioInstitut Pasteur, Université Paris Cité, Malaria Infection and Immunity Unit, Paris, France.
Rogerio AminoInstitut Pasteur, Université Paris Cité, Malaria Infection and Immunity Unit, Paris, France.
Artur ScherfInstitut Pasteur, Université Paris Cité, CNRS ERL9195 and Inserm U1201, Unité de Biologie des Interactions Hôte Parasites, Paris, France.
Olivier SilvieSorbonne Université, Inserm U1135, CNRS ERL 8255, Paris, France.
Salaheddine MecheriInstitut Pasteur, Université Paris Cité, CNRS ERL9195 and Inserm U1201, Unité de Biologie des Interactions Hôte Parasites, Paris, France.
Biologie des interactions hôte-parasiteInserm · FRInstitut Pasteur · FRUniversité Paris Cité · FRCentre National de la Recherche Scientifique · FRInstitut de l’Elevage · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Considering that IL-6 as a critical pro-inflammatory signal, we explored a novel approach whereby the parasite itself encodes for the murine IL-6 gene. We generated transgenic Results and Discussion: Though IL-6 transgenic SPZ developed into exo-erythrocytic forms in hepatocytes

Indexed as

Liver DiseasesMalaria VaccinesAnimalsCD8-Positive T-LymphocytesInterleukin-6MammalsMicePlasmodium bergheiInterleukin-6interleukin-6, mouseMalaria VaccinesCD8 T cellsIL-6inflammationlivermalariavaccine

Identifiers

PMID37143657
PMCPMC10152192
OpenAlexW4364368479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.